KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nov (NOV) Gains from Sales and Divestitures (2016 - 2025)

Historic Gains from Sales and Divestitures for Nov (NOV) over the last 16 years, with Q4 2025 value amounting to $2.9 million.

  • Nov's Gains from Sales and Divestitures fell 556.48% to $2.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.9 million, marking a year-over-year decrease of 556.48%. This contributed to the annual value of $2.9 million for FY2025, which is 556.48% down from last year.
  • Nov's Gains from Sales and Divestitures amounted to $2.9 million in Q4 2025, which was down 556.48% from $3.1 million recorded in Q4 2024.
  • In the past 5 years, Nov's Gains from Sales and Divestitures ranged from a high of $3.1 million in Q4 2024 and a low of $2.7 million during Q4 2021
  • Its 5-year average for Gains from Sales and Divestitures is $2.9 million, with a median of $2.9 million in 2025.
  • As far as peak fluctuations go, Nov's Gains from Sales and Divestitures tumbled by 1725.02% in 2021, and later soared by 714.23% in 2022.
  • Nov's Gains from Sales and Divestitures (Quarter) stood at $2.7 million in 2021, then increased by 7.14% to $2.9 million in 2022, then grew by 6.35% to $3.0 million in 2023, then increased by 0.78% to $3.1 million in 2024, then decreased by 5.56% to $2.9 million in 2025.
  • Its last three reported values are $2.9 million in Q4 2025, $3.1 million for Q4 2024, and $3.0 million during Q4 2023.